The VICC.ORG Directory of Cancers: Treatments, Services & Resources

Childhood Cancers

The Division of Hematology and Oncology at Monroe Carell Jr. Children's Hospital at Vanderbilt includes a dedicated faculty and staff who work together as a team in the diagnosis and treatment of children with cancer or blood diseases. The division also supports a variety of clinical and research programs, a consultation service, and a fellowship training program.


Clinical Trials for Pediatric Cancers

24 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
Basic ScienceCOGAHOD04B1
10/05/2011
AHOD04B1 - Hodgkin Disease (HD) Banking Study
Basic ScienceCOGAALL08B1
10/18/2010
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Basic ScienceCOGAALL05B1
12/01/2006
A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens
Basic ScienceCOGANHL04B1
09/14/2006
Rare and Cutaneous Non-Hodgkin Lymphoma Registry
DiagnosticVICCSAR1275
03/21/2013
Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
OtherVICCPED0987
04/08/2010
The ADVANCE Trial: A Multicenter Validation Study of Biomarkers of Vincristine Peripheral Neuropathy in Children with Acute Lymphoblastic Leukemia
OtherVICCPED0995
02/18/2010
Detection of Donor-Derived DNA in Semen Samples Among Recipients of Allogeneic Hematopoietic Stem-Cell Transplants
OtherVICCPED0974
09/10/2009
Avoidance of Sun Exposure in Patients who Have Had Allogenic Stem Cell Transplants: Effects on Vitamin D Levels and Bone Turnover Markers
OtherVICCPED0710
03/16/2007
Long Term Effects for Childhood Cancer Survivors
OtherCOGALTE03N1
04/20/2005
Key Adverse Events after Childhood Cancer
PreventionVICCPED12112
01/04/2013
NMTRC003: A Phase II Preventative Trial of DFMO (eflornithine HCI) as a Single Agent in Patients with High Risk Neuroblastoma in Remission
Supportive CareCOGACCL0933
11/16/2011
A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
Supportive CareVICCPED0921
05/01/2009
Expanded Access of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD.
TreatmentVICCPED1338
06/27/2013
T2009-012 - A Phase I Dose Finding Study of Panobinostat in Children with Refractory Hematologic Malignancies
TreatmentCOGANBL12P1
06/05/2013
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma
TreatmentVICCPED1249
08/06/2012
An Open Label, Expanded Access Protocol using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients with Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma
TreatmentVICCPED1186
06/11/2012
CA180-372 / AALL1122 - A Phase 2 Multi-Center, Historically-Controlled Study of Dasatinib (IND# 66, 971) Added to Standard Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
TreatmentCOGACNS1022
06/09/2012
ACNS1022 - A Phase II Randomized Trial of Lenalidomide (NSC# 703813, InD# 70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
TreatmentCOGAALL1131
04/05/2012
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND #73789, NSC# 606869) in the Very High Risk Stratum
TreatmentCOGACNS0821
10/08/2011
ACNS0821 - Temozolomide with Irinotecan versus Temozolomide, Irinotecan plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial
TreatmentCOGACNS0831
05/12/2011
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years.
TreatmentCOGADVL0912
04/05/2011
PH 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-MET, in Children With Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma
TreatmentCOGAALL0932
11/11/2010
Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)
TreatmentCOGAALL0631
09/09/2008
A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy =/+ FLT3 Inhibition

You do not have JavaScript enabled. This site works better with JavaScript turned on.